Pacific Center for Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $115K | Buy |
4,775
+8
| +0.2% | +$209 | 0.03% | 141 |
|
|
2026
Q1 | $134K | Buy |
4,767
+264
| +6% | +$7.03K | 0.03% | 122 |
|
|
2025
Q4 | $115K | Hold |
4,503
| – | – | 0.03% | 131 |
|
|
2025
Q3 | $115K | Buy |
4,503
+8
| +0.2% | +$197 | 0.03% | 131 |
|
|
2025
Q2 | $109K | Buy |
4,495
+7
| +0.2% | +$163 | 0.03% | 130 |
|
|
2025
Q1 | $114K | Buy |
4,488
+7
| +0.2% | +$183 | 0.03% | 129 |
|
|
2024
Q4 | $119K | Buy |
4,481
+6
| +0.1% | +$163 | 0.03% | 120 |
|
|
2024
Q3 | $129K | Buy |
4,475
+6
| +0.1% | +$175 | 0.03% | 119 |
|
|
2024
Q2 | $125K | Buy |
4,469
+130
| +3% | +$3.58K | 0.04% | 116 |
|
|
2024
Q1 | $120K | Buy |
4,339
+4
| +0.1% | +$111 | 0.03% | 124 |
|
|
2023
Q4 | $125K | Sell |
4,335
-1,432
| -25% | -$43.3K | 0.04% | 112 |
|
|
2023
Q3 | $191K | Buy |
5,767
+45
| +0.8% | +$1.59K | 0.07% | 76 |
|
|
2023
Q2 | $210K | Buy |
5,722
+2
| +0% | +$78 | 0.07% | 77 |
|
|
2023
Q1 | $233K | Buy |
+5,720
| New | +$247K | 0.08% | 72 |
|
|
2022
Q3 | $258K | Sell |
5,886
-286
| -5% | -$13.9K | 0.1% | 66 |
|
|
2022
Q2 | $324K | Buy |
6,172
+461
| +8% | +$23.5K | 0.13% | 58 |
|
|
2022
Q1 | $296K | Sell |
5,711
-314
| -5% | -$16.3K | 0.11% | 62 |
|
|
2021
Q4 | $356K | Buy |
6,025
+75
| +1% | +$3.72K | 0.14% | 54 |
|
|
2021
Q3 | $256K | Buy |
5,950
+312
| +6% | +$13.8K | 0.11% | 64 |
|
|
2021
Q2 | $221K | Sell |
5,638
-206
| -4% | -$8.01K | 0.1% | 64 |
|
|
2021
Q1 | $212K | Buy |
5,844
+246
| +4% | +$8.73K | 0.1% | 64 |
|
|
2020
Q4 | $206K | Sell |
5,598
-352
| -6% | -$12.9K | 0.08% | 62 |
|
|
2020
Q3 | $207K | Buy |
5,950
+2
| +0% | +$70 | 0.09% | 54 |
|
|
2020
Q2 | $185K | Buy |
5,948
+2
| +0% | +$68 | 0.09% | 55 |
|
|
2020
Q1 | $184K | Hold |
5,946
| – | – | 0.12% | 47 |
|
|
2019
Q4 | $221K | Hold |
5,946
| – | – | 0.1% | 53 |
|
|
2019
Q3 | $203K | Sell |
5,946
-131
| -2% | -$4.76K | 0.1% | 55 |
|
|
2019
Q2 | $250K | Hold |
6,077
| – | – | 0.13% | 45 |
|
|
2019
Q1 | $245K | Hold |
6,077
| – | – | 0.13% | 42 |
|
|
2018
Q4 | $252K | Hold |
6,077
| – | – | 0.14% | 37 |
|
|
2018
Q3 | $254K | Hold |
6,077
| – | – | 0.12% | 43 |
|
|
2018
Q2 | $209K | Hold |
6,077
| – | – | 0.12% | 49 |
|
|
2018
Q1 | $205K | Sell |
6,077
-106
| -2% | -$3.64K | 0.12% | 48 |
|
|
2017
Q4 | $212K | Hold |
6,183
| – | – | 0.13% | 46 |
|
|
2017
Q3 | $209K | Hold |
6,183
| – | – | 0.13% | 48 |
|
|
2017
Q2 | $197K | Buy |
6,183
+132
| +2% | +$4.16K | 0.13% | 48 |
|
|
2017
Q1 | $196K | Hold |
6,051
| – | – | 0.14% | 49 |
|
|
2016
Q4 | $186K | Buy |
+6,051
| New | +$185K | 0.14% | 53 |
|
Other funds holding PFE
Pacific Center for Financial Services's PFE Position: Q2 2026 in Review
Pacific Center for Financial Services increased its Pfizer (PFE) stake by 0.17% in Q2 2026, buying an estimated $209 and bringing the position to 4,775 shares worth $115K. The position accounts for 0.03% of the portfolio, ranked #141.
Pacific Center for Financial Services first reported a position in PFE in Q4 2016 and has held it in 38 quarters since. The position peaked at $356K in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Pacific Center for Financial Services held 4,775 shares of Pfizer worth $115K as of Q2 2026.
- Pacific Center for Financial Services bought 8 Pfizer shares in Q2 2026, an estimated $209.
- Pfizer made up 0.03% of Pacific Center for Financial Services's portfolio in Q2 2026, its #141 holding.
- Pacific Center for Financial Services first reported a position in Pfizer in Q4 2016 and has held it in 38 quarters since.
- Pacific Center for Financial Services's Pfizer position peaked at $356K in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Pacific Center for Financial Services's 13F filing for Q2 2026, filed 5 Aug 2026.